MVMDF (Mountain Valley MD Holdings) Earnings per Share (Diluted): $0.00 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Mountain Valley MD Holdings Earnings per Share (Diluted)?

Mountain Valley MD Holdings MVMDF +3.64% Earnings per Share (Diluted) is $0.00 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 791 Drug Manufacturers companies, Mountain Valley MD Holdings ranks better than 63.46% on this metric.

Mountain Valley MD Holdings's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

Mountain Valley MD Holdings's EPS (Basic) for the three months ended in Mar. 2026 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

Mountain Valley MD Holdings's EPS without NRI for the three months ended in Mar. 2026 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00.

During the past 3 years, the average EPS without NRIGrowth Rate was 17.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 21.40% per year.

During the past 7 years, Mountain Valley MD Holdings's highest 3-Year average EPS without NRI Growth Rate was 35.90% per year. The lowest was 0.00% per year. And the median was 24.90% per year.


Mountain Valley MD Holdings  (OTCPK:MVMDF) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Mountain Valley MD Holdings Earnings per Share (Diluted) Related Terms


Mountain Valley MD Holdings Earnings per Share (Diluted) Historical Data

* Premium members only.

The historical data trend for Mountain Valley MD Holdings's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mountain Valley MD Holdings Earnings per Share (Diluted) Chart

Mountain Valley MD Holdings Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Earnings per Share (Diluted)
Get a 7-Day Free Trial -0.02 -0.02 -0.02 -0.01 -0.01

Mountain Valley MD Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.00 0.00 0.00 0.00

MVMDF vs ZTS: Earnings per Share (Diluted) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mountain Valley MD Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mountain Valley MD Holdings PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mountain Valley MD Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Mountain Valley MD Holdings's PE Ratio falls into.



Mountain Valley MD Holdings Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Mountain Valley MD Holdings's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2026 is calculated as

Diluted Earnings Per Share (A: Mar. 2026 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.038-0)/352.355
=-0.01

Mountain Valley MD Holdings's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2026 is calculated as

Diluted Earnings Per Share (Q: Mar. 2026 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-0.53-0)/352.355
=-0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

What does a Earnings per Share (Diluted) of $0.00 mean?
Mountain Valley MD Holdings (MVMDF) has a Earnings per Share (Diluted) of $0.00 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Mountain Valley MD Holdings and its competitors. According to the industry distribution chart, Mountain Valley MD Holdings ranks #289 out of 791 companies in the Drug Manufacturers industry, placing it in the top 36.5%.
Is Mountain Valley MD Holdings' Earnings per Share (Diluted) too high?
Mountain Valley MD Holdings' current Earnings per Share (Diluted) is $0.00. Based on the distribution chart, Mountain Valley MD Holdings ranks #289 out of 791 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Mountain Valley MD Holdings' Earnings per Share (Diluted) compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mountain Valley MD Holdings ranks #289 out of 791 companies for Earnings per Share (Diluted). This puts Mountain Valley MD Holdings in the upper half of its industry. The industry median Earnings per Share (Diluted) is 9.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Drug Manufacturers company?
The median Earnings per Share (Diluted) among Drug Manufacturers companies is 9.70, based on 791 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Mountain Valley MD Holdings and its competitors. For the Drug Manufacturers industry, the median Earnings per Share (Diluted) is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mountain Valley MD Holdings's current Earnings per Share (Diluted) is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mountain Valley MD Holdings stock overvalued right now?
Mountain Valley MD Holdings (MVMDF) has a current Earnings per Share (Diluted) of $0.00. The current Earnings per Share (Diluted) is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Mountain Valley MD Holdings (MVMDF), the current Earnings per Share (Diluted) is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mountain Valley MD Holdings Business Description

Other Exchanges 20MP:GermanyMVMD:Canada
Address 260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm, along with its subsidiaries, is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The company actively invests in and collaborates on pioneering biotechnologies that have the potential to revolutionize the human health and wellness landscape, drive sustainable increases in plant yields and agricultural farming practices, and broadly support animal husbandry health. The Company is a biotech company focused on advancing solutions to optimize human, animal, and plant health.